Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases
BioSpace » Biotechnology Industry News
by
1M ago
With Versant Ventures as a founding investor, Santa Ana Bio emerged from stealth Thursday with $168 million in combined Series A and B funding to support plans to have two programs in the clinic by next year ..read more
Visit website
Foresite Raises $900M in Sixth Fund to Invest in Life Science Startups
BioSpace » Biotechnology Industry News
by
1M ago
Among the biggest raises this year, Foresite Capital’s $900 million fund will support biotech companies working in precision medicine and life science infrastructure ..read more
Visit website
Moderna’s Next-Gen COVID Vaccine Beats Current Shot in Pivotal Adult Efficacy Trial
BioSpace » Biotechnology Industry News
by
1M ago
Moderna said Thursday it plans to talk to regulators about the next steps after showing its next-generation candidate is more efficacious in adults than the biotech’s existing Spikevax COVID-19 shot ..read more
Visit website
Pfizer’s Gene Therapy for Duchenne Muscular Dystrophy Fails Phase III Trial
BioSpace » Biotechnology Industry News
by
1M ago
Pfizer’s investigational Duchenne muscular dystrophy gene therapy, fordadistrogene movaparvovec, failed in a late-stage study to significantly improve motor function in patients versus placebo ..read more
Visit website
Secondary Cancer Risk Is Low After CAR T Cell Treatment: Stanford Study
BioSpace » Biotechnology Industry News
by
1M ago
Results of a large Stanford Medicine study, published Wednesday in The New England Journal of Medicine, finds CAR-T therapies carry a low risk of secondary malignancies not related to the T cells ..read more
Visit website
BMS’ Augtyro Wins FDA Accelerated Approval for NTRK-Positive Solid Tumors
BioSpace » Biotechnology Industry News
by
1M ago
Based on promising response data from the Phase I/II TRIDENT-1 study, the FDA on Thursday granted Bristol Myers Squibb’s Augtyro accelerated approval for NTRK-positive locally advanced or metastatic solid tumors ..read more
Visit website
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund
BioSpace » Biotechnology Industry News
by
1M ago
J.P. Morgan’s life sciences venture capital arm on Thursday announced it closed its first biotech fund, targeting companies in cardiometabolic disease, immunology, oncology and genetic medicine ..read more
Visit website
Telix Abandons IPO Plans at Last Minute, Cites ‘Current Market Conditions’
BioSpace » Biotechnology Industry News
by
1M ago
Telix abruptly pulled the plug on its initial public offering plans to begin trading Friday on the Nasdaq, saying the company “did not feel that the proposed discounts were aligned with its duty to its existing shareholders ..read more
Visit website
Tris Pharma Gets FDA Approval for Non-Stimulant ADHD Medication
BioSpace » Biotechnology Industry News
by
1M ago
Tris Pharma on Wednesday secured the FDA’s green light for Onyda XR, the first liquid non-stimulant nighttime treatment for attention deficit hyperactivity disorder in pediatric patients ..read more
Visit website
BridgeBio Builds on Positive Phase III Data for Acoramidis in ATTR-CM
BioSpace » Biotechnology Industry News
by
1M ago
Additional analyses from BridgeBio Pharma’s late-stage study show the oral drug candidate improved clinical outcomes in transthyretin amyloid cardiomyopathy patients ..read more
Visit website

Follow BioSpace » Biotechnology Industry News on FeedSpot

Continue with Google
Continue with Apple
OR